Showing results (41-50 of 138) with videos related to
Sort By:
Pageof 14
The Lancet Regional Health. Western Pacific|July 30, 2021
Psychotropic medication utilisation in adult cancer patients in China: A cross-sectional study based on national health insurance databaseLin Bai, Ziyue Xu, Cong Huang, et al.BMC Health Services Research|July 16, 2020
Medical insurance and healthcare utilization among the middle-aged and elderly in China: evidence from the China health and retirement longitudinal study 2011, 2013 and 2015Yue Zhou, Haishaerjiang Wushouer, Daniel Vuillermin, et al.Frontiers in Pharmacology|September 6, 2021
Interventions for Preventing Cardiotoxicity in Breast Cancer Patients Receiving Trastuzumab: A Systemic Review and Bayesian Network Meta-AnalysisXinyi Li, Ziyang Wu, Xin Du, et al.Journal of Pharmaceutical Policy and Practice|April 17, 2026
Reconstructing the professional role of pharmacists in China from the perspective of public value theory: challenges and institutional pathwaysKexin Han, Shushan Wu, Fanghui Lin, et al.Frontiers in Psychiatry|July 11, 2022
Systematic Review and Meta-Analysis of Vortioxetine for the Treatment of Major Depressive Disorder in AdultsXinyan Zhang, Yuchun Cai, Xiaowen Hu, et al.Clinical Epidemiology|December 19, 2019
Medication Use During Pregnancy in Mainland China: A Cross-Sectional Analysis of a National Health Insurance DatabaseJingyuan Zhang, Carolina Oi Lam Ung, Anita Katharina Wagner, et al.Frontiers in Pharmacology|September 26, 2022
Trends in the utilization of psychotropic medications in China from 2018 to 2021Xinyan Zhang, Xiaowen Hu, Yuxuan Zhao, et al.Pharmacoepidemiology and Drug Safety|June 10, 2020
Potentially inappropriate medications among elderly patients in community healthcare institutions in Beijing, ChinaMengyuan Fu, Haishaerjiang Wushouer, Xiaoyan Nie, et al.Seminars in Oncology|April 20, 2021
Can locally developed me-too drugs aid price negotiation? An example of cancer therapies from ChinaZhenhuan Luo, Bishal Gyawali, Sheng Han, et al.Journal of Global Health|August 11, 2023
The impact of government reimbursement negotiation on targeted anticancer medicines use and cost in China: A cohort study based on national health insurance dataYu Yang, Yichen Zhang, Anita K Wagner, et al.Pageof 14